HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.

Saved in:
Bibliographic Details
Title: HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
Authors: Alderuccio JP; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL., Olszewski AJ; Division of Hematology/Oncology, Brown University, Providence, RI., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Collins GP; NIHR Oxford Biomedical Research Centre, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford., Danilov AV; City of Hope National Medical Center, Duarte, CA., Bower M; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Jagadeesh D; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Zhu C; University College London Hospital, London, United Kingdom., Sperling A; Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Kim SH; Rush University Medical Center, Chicago, IL., Vaca R; Penn State Cancer Institute, College of Medicine, Penn State University, Hershey, PA., Wei C; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Sundaram S; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Reddy N; Vanderbilt University Medical Center, Nashville, TN., Dalla Pria A; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., D'Angelo C; Carbone Cancer Center, University of Wisconsin, Madison, WI., Farooq U; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Bond DA; James Cancer Center, The Ohio State University Hospital, Columbus, OH., Berg S; Loyola University Medical Center, Maywood, IL., Churnetski MC; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Godara A; Tufts Medical Center, Boston, MA., Khan N; Fox Chase Cancer Center, Philadelphia, PA., Choi YK; New York University (NYU) Cancer Institute, School of Medicine, NYU, New York, NY., Kassam S; King's College Hospital, London, United Kingdom., Yazdy M; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC., Rabinovich E; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL., Post FA; King's College Hospital, London, United Kingdom., Varma G; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY., Karmali R; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Burkart M; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Martin P; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY., Ren A; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL., Chauhan A; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC., Diefenbach C; New York University (NYU) Cancer Institute, School of Medicine, NYU, New York, NY., Straker-Edwards A; Fox Chase Cancer Center, Philadelphia, PA., Klein A; Tufts Medical Center, Boston, MA., Blum KA; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Boughan KM; University Hospitals Seidman Cancer Center, Cleveland, OH., Mian A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Haverkos BM; Division of Hematology, University of Colorado, Denver, CO., Orellana-Noia VM; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Kenkre VP; Carbone Cancer Center, University of Wisconsin, Madison, WI., Zayac A; Division of Hematology/Oncology, Brown University, Providence, RI., Maliske SM; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Epperla N; James Cancer Center, The Ohio State University Hospital, Columbus, OH., Caimi P; University Hospitals Seidman Cancer Center, Cleveland, OH., Smith SE; Loyola University Medical Center, Maywood, IL., Kamdar M; Division of Hematology, University of Colorado, Denver, CO., Venugopal P; Rush University Medical Center, Chicago, IL., Feldman TA; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Rector D; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Smith SD; Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Stadnik A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Portell CA; University of Virginia Cancer Center, Charlottesville, VA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Naik S; Penn State Cancer Institute, College of Medicine, Penn State University, Hershey, PA., Montoto S; St Bartholomew's and The Royal London NHS Trust, London, United Kingdom., Lossos IS; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL., Cwynarski K; University College London Hospital, London, United Kingdom.
Source: Blood advances [Blood Adv] 2021 Jul 27; Vol. 5 (14), pp. 2852-2862.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2021004458